Aprea Therapeutics
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Healthtech
Funding summary
- Total raised
- €5.0M
- Funding rounds
- 1
Investors in Aprea Therapeutics
Investors on record for Aprea Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Aprea Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors